首页> Gastroenterology> Immune Cell and Stromal Signature Associated With Progression-Free Survival of Patients With Resected Pancreatic Ductal Adenocarcinoma

Immune Cell and Stromal Signature Associated With Progression-Free Survival of Patients With Resected Pancreatic Ductal Adenocarcinoma

导出原文传递

翻译打印收藏纠错

第一作者： Ujjwal Mukund Mahajan

作者： Ujjwal Mukund Mahajan ^[1] ; Eno Langhoff ^[2] ; Elisabetta Goni ^[3] ; Eithne Costello ^[4] ; William Greenhalf ^[5] ; Christopher Halloran ^[6] ; Steffen Ormanns ^[7] ; Stephan Kruger ^[8] ; Stefan Boeck ^[9] ; Silvia Ribback ^[10] ; Georg Beyer ^[11] ; Frank Dombroswki ; Frank-Ulrich Weiss ; John P. Neoptolemos ; Jens Werner ; Jan G. D’Haese ; Alexandr Bazhin ; Julian Peterhansl ; Svenja Pichlmeier ; Markus W. Büchler ; J?rg Kleeff ; Paula Ganeh ; Matthias Sendler ; Daniel H. Palmer ; Thomas Kohlmann ; Roland Rad ; Ivonne Regel ; Markus M. Lerch ; Julia Mayerle

作者单位： Department of Pathology, University Medicine Greifswald ^[1] Institute of Translational Medicine, University of Liverpool ^[2] Institute of Pathology, Faculty of Medicine, LMU Munich ^[3] Department of General, Visceral and Transplantation Surgery, University of Heidelberg ^[4] Department of General, Visceral, and Transplant Surgery, Ludwig-Maximilians-University Munich ^[5] Department of Medicine A, University Medicine Greifswald ^[6] Department of Medicine III, University Hospital, LMU Munich ^[7] Department of Community Medicine, University Medicine Greifswald ^[8] Center for Translational Cancer Research (TranslaTUM), Technische Universit?t München ^[9] Department of Medicine II, University Hospital, LMU Munich ^[10] Department of Visceral, Vascular and Endocrine Surgery, Martin-Luther University Halle-Wittenberg ^[11]

关键词 ESPAC Pancreatic Cancer Histologic Analysis Prognostic Factor

发布时间 2019-06-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交